Regulation of tissue regeneration and homeostasis through ON-OFFcontrol of the Met/HGF receptor
Regulation of tissue regeneration and homeostasis through ON-OFFcontrol of the Met/HGF receptor
批准号:
18570127
负责人:
MATSUMOTO Kunio
金额:
$2.63万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
肝细胞生长因子(HGF)和Met/HGF受体酪氨酸激酶在组织再生中起重要作用。在未损伤的正常组织中,即使在与HGF结合后,Met活化/酪氨酸磷酸化也受到抑制。因此,HGF依赖性Met受体活化不仅可以通过HGF结合调节,还可以通过细胞环境如细胞-细胞接触和细胞损伤调节。本研究通过细胞间接触和Met跨膜结构域Ser 985磷酸化来研究Met激活的抑制机制.在稀疏细胞密度下培养的肝细胞中,HGF诱导Met活化延长和显着的促有丝分裂反应。与此相反,肝细胞生长因子诱导短暂的Met激活,但未能诱导细胞间紧密接触的融合肝细胞的促有丝分裂反应。蛋白酪氨酸磷酸酶,LAR的表达增加后,HGF刺激,特别是在汇合的肝细胞。LAR与Met和去磷酸化ty相关 ...更多信息 磷酸化蛋氨酸因此,LAR和Met的功能关联是细胞-细胞接触抑制HGF依赖性Met活化的抑制机制的基础.在培养的肝细胞中,当Ser 985被磷酸化时,HGF依赖的Met酪氨酸磷酸化/激活被抑制。在正常肝脏中,Met Ser 985被磷酸化,然而,Ser 985在肝损伤如部分肝切除后被去磷酸化。肝损伤后Met与Ser 985磷酸化呈交互作用。结果表明,丝氨酸985在甲硫氨酸的质膜结构域的组织损伤和丝氨酸985磷酸化的甲硫氨酸的质膜结构域可能是一种机制,通过这种机制,HGF依赖的甲硫氨酸激活被抑制在非损伤器官。由于Met受体与内膜缺失后天然表达为剪接变异体,因此Met的内膜可能在组织损伤后调节HGF依赖的Met活化中发挥重要作用.本研究利用仅表达缺失了甲硫氨酸跨膜结构域的变异体的转基因小鼠,研究了甲硫氨酸跨膜结构域在发育和组织再生中的生理意义。少
英文摘要
HGF (hepatocyte growth factor) and Met/HGF receptor tyrosine kinase play important roles in tissue regeneration. In non-injured normal tissues, Met activation/tyrosine phosphorylation is suppressed even following binding with HGF. Thus, HGF-dependent Met receptor activation may be regulated by not only HGF-binding but also cellular context such as cell-cell contact and cellular injury. In this research, suppressive mechanisms of Met activation through cell-cell contact and Ser985 phosphorylation in the juxtamembrane domain of the Met were investigated.1. In hepatocytes cultured at a sparse cell density, HGF induced prolonged Met activation and a marked mitogenic response. In contrast, HGF induced transient Met activation but failed to induce mitogenic response in confluent hepatocytes with tight cell-cell contact. Expression of the protein tyrosine phosphatase, LAR increased following HGF-stimulation specifically in confluent hepatocytes. LAR associated with Met and dephosphorylated ty … More rosine-phosphorylated Met. Thus functional association of LAR and Met underlies the inhibitory mechanism by which HGF-dependent Met activation is suppressed by cell-cell contact.2. In hepatocytes in culture, HGF-dependent Met tyrosine phosphorylation/activation was inhibited when Ser985 was phosphorylated. In the normal liver, Met Ser985 was phosphorylated, however, Ser985 was dephosphorylated after hepatic injury such as partial hepatectomy. In reciprocal manner to Ser985 phosphorylation, Met was activated after hepatic injury. The results suggest that Ser985 in the juxtamembrane domain of Met is regulated by tissue injury and that Ser985 phosphorylation in the juxtamembrane domain of Met may be a mechanism by which HGF-dependent Met activation is suppressed in non-injured organs. Because Met receptor deleted with the juxtamembrane is naturally expressed as a splicing variant, the juxtamembrane of the Met may play an important role in regulation of HGF-dependent Met activation in response to tissue injury.3. Physiological significance of the juxtamembrane domain of Met in the development and tissue regeneration is investigated using the transgenic mice which express only variant Met deleted with the juxtamembrane domain. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Hepatocyte growth factor attenuates cerebral ischemia-induced increase in permeability of blood-brain barrier and decreases in expression of tight junctional proteins in cerebral vessels.
肝细胞生长因子可减弱脑缺血引起的血脑屏障通透性增加和脑血管中紧密连接蛋白表达的减少。
DOI:
--
发表时间:
2006
期刊:
Neurosci Lett. 407
影响因子:
--
作者:
[Date, I., Takagi, N., Takagi, K., Tanonaka, K., Funakoshi, H., Matsumoto, K., Nakamura, T., akeo, S, Machide M. et al., Sumi T.et al., Matsumoto K. et al., Namiki Y. et al., Hosseinkhani H. et al., Azuma J. et al., Ogura Y. et al., Tada T.et al., Ono K.et al., Niimura M. et al., Date I.et al.]
通讯作者:
Date I.et al.
NK4による血管新生阻害機槽:NK4による接着斑形成とフィプロネクチン構築の阻害
NK4抑制血管生成的机制:NK4抑制粘着斑形成和纤连蛋白组装
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Matsumoto, K., Nakamura, T., Sakai, K., Nakamura, T, 酒井 克也, 酒井 克也]
通讯作者:
酒井 克也
再生医療のための細胞生物学(関口清俊編) コロナ社
再生医学的细胞生物学(关口清俊编辑)Coronasha
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Matsumoto K., et. al., 松本 邦夫]
通讯作者:
松本 邦夫
喘息治療剤
哮喘治疗剂
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.2741/2813
发表时间:
2008-01-01
期刊:
FRONTIERS IN BIOSCIENCE-LANDMARK
影响因子:
3.1
作者:
[Matsumoto, Kunio, Nakamura, Toshikazu]
通讯作者:
Nakamura, Toshikazu
共 69 条
Mechanisms for malignant tumor progression based on acquisition of 3-D invasiveness and regulation of epithelial morphogenesis
-
批准号:24300329
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.4万
-
财政年份:2012
-
负责人:MATSUMOTO Kunio
-
依托单位:
Research on tissue regeneration regulated by Met/HGF receptor ON-OFF regulation
-
批准号:20390077
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.65万
-
财政年份:2008
-
负责人:MATSUMOTO Kunio
-
依托单位:
Development of a high-sensitive method of γ-aminobutyric acid with a novel γ-aminobutyric acid oxidase
-
批准号:15560680
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:2003
-
负责人:MATSUMOTO Kunio
-
依托单位:
Tissue regeneration and homeostasis through functional Met/HGF receptor modification associated with tissue injury.
-
批准号:13470037
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.72万
-
财政年份:2001
-
负责人:MATSUMOTO Kunio
-
依托单位:
Vascular regulation by kringles of HGF and molecular cloning of a novel kringle-containing protein
-
批准号:11680631
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:1999
-
负责人:MATSUMOTO Kunio
-
依托单位:
Anti-fibrogenic analysis of HGF in intractable organ failures: Clinical potential of HGF as regenerative therapy
-
批准号:11557010
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.35万
-
财政年份:1999
-
负责人:MATSUMOTO Kunio
-
依托单位:
Roles of HGF and its family molecules in development.
-
批准号:07044201
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$5.89万
-
财政年份:1995
-
负责人:MATSUMOTO Kunio
-
依托单位:
INDUCTION OF HGF AFTER LIVER INJURIES AND IDENTIFICATION OF INDUCER FOR HGF
-
批准号:03680173
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.02万
-
财政年份:1991
-
负责人:MATSUMOTO Kunio
-
依托单位:
国内基金
海外基金
登录
查看更多内容
金荞麦黄酮靶向抑制c-MET介导的PI3K/Akt和Ras/MAPK通路逆转NSCLC EGFR-TKI耐药的机制研究
-
批准号:2026JJ81256
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李弘德
-
依托单位:
Gal9+TAMs经旁分泌塑造新型Gal9-Met互作轴驱动肝癌免疫逃逸的分子机制及干预策略
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:杨文静
-
依托单位:
抗体药物偶联物(ADC)阻断MET通路对骨肉瘤靶向治疗的研究
-
批准号:2025JJ80738
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:曾鸣
-
依托单位:
复方香巴戟膏介导的NO/HGF/c-met通路活化卫星细胞促进损伤后肌肉组织再生
-
批准号:2025JJ70694
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:丁轩
-
依托单位:
时序释放Met/Qct-MPs葡萄糖响应型水凝胶对糖尿病创面微环境调节机制的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:郭菁菁
-
依托单位:
MET介导代谢修饰调控肌-骨线粒体转移促进衰老状态骨再生的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:顾浩
-
依托单位:
安罗替尼通过调控HGF/c-MET信号通路与自噬相互作用促进人脑胶质瘤细胞凋亡的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘细帮
-
依托单位:
新型靶向c-MET/EGFR小分子抑制剂ZP-32克服EGFR TKI MET扩增耐药的非小细胞肺癌脑转作用及机制研究
-
批准号:2025JJ70229
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘兰
-
依托单位:
非小细胞肺癌 MET-TKI 获得性耐药的分子机制探索及药物筛选
-
批准号:2024JJ7468
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:刘新福
-
依托单位:
基于核酸适体的原位共价标记技术用于精准高效调控
c-Met 蛋白功能
-
批准号:2024JJ6017
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:陈坤
-
依托单位: